PharmaPrint Inc.: The Irvine pharmaceutical manufacturer, formerly...
- Share via
PharmaPrint Inc.: The Irvine pharmaceutical manufacturer, formerly ABT Global Pharmaceutical, reported a net loss of $4.5 million, or 46 cents a share, for the second fiscal quarter ended Sept. 30, compared with a net loss of $165,986, or 2 cents a share, for the same period a year ago. For the six-month period, the company posted a net loss of $7 million, or 79 cents a share, compared with a loss of $313,492, or 4 cents a share, for the first half last year. No revenue was recorded.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.